 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Diana Cittelly and David Camidge.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.449 |
|
|
|
-
Camidge DR, Phillips WJ, Nemenoff RA, Cittelly DM. A Response to the Letter to the Editor: Supporting a Neuroprotective Effect of Lorlatinib Across ALK and ROS1 Targets. J Thorac Oncol. 2026 Jul; 21(7):103727.
Score: 0.993
-
Camidge DR, Phillips WJ, Nemenoff RA, Cittelly DM. Hiding in Plain Sight: The Neuro-Protective Benefit of Tropomyosin Receptor Kinase Inhibition in Non-Neurotrophic Receptor Tyrosine Kinase-Driven Lung Cancers. J Thorac Oncol. 2026 Apr; 21(4):103545.
Score: 0.963
-
Contreras-Zárate MJ, Jaramillo-Gómez JA, Marquez-Ortiz RA, Pham TC, Koliavas S, Ormond DR, Navarro AC, Nemenoff RA, Camidge DR, Cittelly DM. Targeting wild-type NTRK in NTRK fusion negative lung cancer decreases brain metastases. Cancer Res Commun. 2026 Jul 21.
Score: 0.249
-
Contreras-Zárate MJ, Jaramillo-Gómez JA, Marquez-Ortiz RA, Pham TC, Koliavas S, Ormond DR, Navarro AC, Nemenoff RA, Camidge DR, Cittelly DM. Targeting wild type NTRK decreases brain metastases of lung cancers non-driven by NTRK fusions. bioRxiv. 2026 Mar 20.
Score: 0.243
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|